| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/01/2007 | US20070027309 Nucleic acid and amino acid sequences relating to Candida albicans for diagnostics and therapeutics |
| 02/01/2007 | US20070027306 With improved shelf life and storage stability; expression vectors and host cells; therapeutic proteins are chemically or genetically fused to albumin; hypoglycemic agents, analgesics; retinopathy, cardiovascular disease, obesity, renal disease, neuropathy |
| 02/01/2007 | US20070027304 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070027291 Structure and method for producing structure, toner containing structure, image forming method and device using toner |
| 02/01/2007 | US20070027103 Methods and compositions for silencing genes without inducing toxicity |
| 02/01/2007 | US20070027096 Aptamers to human epidermal growth factor receptor-3 |
| 02/01/2007 | US20070027086 use for treatment of medical and veterinary conditions which can be influenced by the MC1-receptor; act as antiinflammatory and immunomodulatory agent; inhibit the production of nitric oxide (NO) |
| 02/01/2007 | US20070027078 Isolated proteins from a traditional Chinese medicine Yuzhu and use thereof |
| 02/01/2007 | US20070026521 Polynucleotides for use in recombinant adeno-associated virus virion production |
| 02/01/2007 | US20070026514 Electromagnetic treatment apparatus for enhancing pharmacological, chemical, and topical agent effectiveness and method for using same |
| 02/01/2007 | US20070026505 Amino acid and metabolite biosynthesis |
| 02/01/2007 | US20070026504 Method for producing l-fuculose and method for producing l-fucose |
| 02/01/2007 | US20070026499 nucleotide or DNA constructs comprising expression cassettes comprising promoters operably linked to transgene open reading frames, used in protein production, diagnostics, transgenic plants and animals and the therapeutic field |
| 02/01/2007 | US20070026498 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/01/2007 | US20070026496 Process for Producing Polypeptides |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026492 Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties |
| 02/01/2007 | US20070026487 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2007 | US20070026486 chimera; nuclear factor kappa beta; vectors, host cell; gene therapy; pharmacokinetics |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026466 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 02/01/2007 | US20070026464 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 02/01/2007 | US20070026462 bacteriophage comprising a promoter operably linked to a nucleic acid sequence encoding a GAS1 secretion signal peptide; for generating an immunoglobulin variable domain polypeptide library and for the generation of single domain antibodies themselves |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |
| 02/01/2007 | US20070026449 Novel human sodium-dependent phosphate cotransporter |
| 02/01/2007 | US20070026447 Nucleotides |
| 02/01/2007 | US20070026446 Enhanced genome copy number, and capacity for expression and/or secretion of proteins and secondary metabolites |
| 02/01/2007 | US20070026445 Novel steroid-activated nuclear receptors and uses therefor |
| 02/01/2007 | US20070026434 Mobility-Modified Nucleobase Polymers and Methods of Using Same |
| 02/01/2007 | US20070026429 Binary probe and clamp composition and methods for target hybridization detection |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026402 Genetic marker of response to atypical antipsychotics and antidepressants methods for use thereof |
| 02/01/2007 | US20070026397 Method for producing second-generation library |
| 02/01/2007 | US20070026396 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 02/01/2007 | US20070026395 Human cancer-relating genes, the products encoded thereby and applications thereof |
| 02/01/2007 | US20070026394 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies |
| 02/01/2007 | US20070026379 Collection Systems for Cytometer Sorting of Sperm |
| 02/01/2007 | US20070026104 Alcohol dehydrogenase gene of acetic acid bacterium |
| 02/01/2007 | US20070026076 Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins |
| 02/01/2007 | US20070026022 Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens |
| 02/01/2007 | US20070026017 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 02/01/2007 | US20070026016 site-directed mutagenesis; immunogens; vaccines |
| 02/01/2007 | US20070026012 Compositions and methods for monitoring and altering protein folding and solubility |
| 02/01/2007 | US20070026011 Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
| 02/01/2007 | US20070026010 Purification process for bacterial cytolysin |
| 02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
| 02/01/2007 | US20070025996 Oculospanin as a tumor specific antigen and methods and compositions utilizing same |
| 02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 02/01/2007 | US20070025993 Tek antagonists |
| 02/01/2007 | US20070025992 Monoclonal antibody against platelet membrane glycoprotein VI |
| 02/01/2007 | US20070025984 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 02/01/2007 | US20070025981 Microorganisms for therapy |
| 02/01/2007 | US20070025971 Substances causing differentiation |
| 02/01/2007 | US20070025970 Vector system |
| 02/01/2007 | US20070025969 RNAi expression constructs |
| 02/01/2007 | US20070025968 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes |
| 02/01/2007 | US20070025961 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | DE102005035888A1 New transgenic cereal plants that express the sweetener thaumatin, also related nucleic acid, protein, vectors and malted or milled products for use in foods |
| 02/01/2007 | DE10196565B4 Rekombinantes Human-Parathyroidhormon erzeugender Hefe-Transformant und Verfahren zur Herstellung des Hormons Recombinant human parathyroid hormone-producing yeast transformant and methods for producing the hormone |
| 02/01/2007 | DE10141443B4 Verwendung von molekularbiologisch hergestellten, nicht-viralen Wirkstoffen zur Behandlung der Akne Using molecular biological manufactured, non-viral agents for the treatment of acne |
| 02/01/2007 | CA2617353A1 Graded expression of snail as marker of cancer development and dna damage-based diseases |
| 02/01/2007 | CA2616805A1 Targeting-enhanced activation of galectins |
| 02/01/2007 | CA2616766A1 Antibody profiles characteristic of tuberculosis state |
| 02/01/2007 | CA2616395A1 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 02/01/2007 | CA2616099A1 Novel anti-igf-ir antibodies and uses thereof |
| 02/01/2007 | CA2616087A1 Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof |
| 02/01/2007 | CA2615983A1 Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis |
| 02/01/2007 | CA2615837A1 Combination of lipid metabolism proteins and uses thereof |
| 02/01/2007 | CA2615615A1 Anti-cd26 antibodies and methods of use thereof |
| 02/01/2007 | CA2615532A1 Targeted integration and expression of exogenous nucleic acid sequences |
| 02/01/2007 | CA2614039A1 Compositions and methods of treating disease with fgfr fusion proteins |
| 02/01/2007 | CA2607668A1 Rnai modulation of the rho-a gene and uses thereof |
| 01/31/2007 | EP1748082A1 Method of analyzing nucleic acid |
| 01/31/2007 | EP1748078A2 Methods, kits and compositions of combination oligomers |
| 01/31/2007 | EP1748077A1 Method of producing protein |
| 01/31/2007 | EP1748076A1 Process for producing hydroxycarboxylic acid |
| 01/31/2007 | EP1748075A1 Recombinant chemokine-antigen vaccine |
| 01/31/2007 | EP1748074A2 Method for the in situ production of an emulsifier in a foodstuff |
| 01/31/2007 | EP1748073A1 Recombinant d-amino acid oxidase |
| 01/31/2007 | EP1748072A1 Hydroxysilane functionalized magnetic particles and nucleic acid separation method |
| 01/31/2007 | EP1748071A1 Process for producing polypeptide |
| 01/31/2007 | EP1748070A1 Therapeutic medicine containing monoclonal antibody against folate receptor beta (fr-beta) |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1748068A1 Method of breeding lipid-producing strain and utilization of the same |
| 01/31/2007 | EP1748062A1 Succinic acid-producing bacterium and process for producing succinic acid |
| 01/31/2007 | EP1748050A1 Targeting-enhanced activation of galectins |
| 01/31/2007 | EP1747784A1 Target gene mimitin of myc |
| 01/31/2007 | EP1747462A2 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 01/31/2007 | EP1747293A2 Compositions and methods for producing libraries with controlled compositions and screening probabilites |
| 01/31/2007 | EP1747284A2 Diagnosis and therapeutics for cancer |
| 01/31/2007 | EP1747280A2 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins |
| 01/31/2007 | EP1747277A1 Method for gene delivery to neuronal cells |
| 01/31/2007 | EP1747276A2 Carotenoid biosynthesis inhibitor resistance genes and methods of use in plants |
| 01/31/2007 | EP1747275A2 Novel nucleic acid sequences and their use in methods for achieving a pathogenic resistance in plants |
| 01/31/2007 | EP1747274A1 Preparation method for the production of active and soluble proteins in prokaryotes and polycistronic vectors therefor |
| 01/31/2007 | EP1747273A2 Gene-cassette for enhancement of protein production |
| 01/31/2007 | EP1747272A2 Expression cassette |
| 01/31/2007 | EP1747271A1 Method for extracting nucleic acid and nucleic acid-extracting apparatus |
| 01/31/2007 | EP1747263A2 Improved prebiotic |